首页|肿瘤中长链非编码RNA LINC01503的表达及分子调控研究进展

肿瘤中长链非编码RNA LINC01503的表达及分子调控研究进展

Expression and molecular regulation research progress of long non-coding RNA LINC01503 in tumors

扫码查看
长链非编码RNA(lncRNA)是一类长度超过200个核苷酸的非编码RNA,在染色体修饰、转录调控以及转录后加工等水平调控基因的表达,从而影响肿瘤的发生发展,探究lncRNA在肿瘤中的分子调控机制是近几年来研究热点之一.现有研究证实LINCO1503是一种在鳞状细胞癌研究中新近发现的长链非编码RNA,在结直肠癌、卵巢癌、肺癌及胶质瘤等诸多人类肿瘤中呈现显著高表达,其异常表达常与患者不良预后密切相关,并且能够通过ceRNA机制、上皮间质转化、参与多种相关信号通路以及表观遗传修饰等途径促进肿瘤细胞的恶性生物学行为,包括细胞增殖、迁移、侵袭和抗凋亡等;对LINC01503作用的研究有助于相关肿瘤的诊断、治疗及评估预后.本文就LINC01503在肿瘤中的表达及分子调控研究进展进行综述.
Long non-coding RNA(lncRNA)is a class of non-coding RNA molecules with lengths exceeding 200 nu-cleotides.They play a crucial role in regulating gene expression at various levels,such as chromatin modification,transcrip-tional control,and post-transcriptional processing,thereby influencing the development and progression of tumors.Investi-gating the molecular regulatory mechanisms of lncRNAs in cancer has become a hot topic in recent years.Existing research has confirmed that LINC01503 is a newly discovered long non-coding RNA in squamous cell carcinoma.It exhibits signifi-cant overexpression in various human cancers,including colorectal cancer,ovarian cancer,lung cancer,and glioblastoma.Its abnormal expression is closely associated with poor patient prognosis.Furthermore,LINC01503 is involved in promoting malignant biological behaviors of tumor cells,including cell proliferation,migration,invasion,and anti-apoptosis,through mechanisms such as ceRNA regulation,epithelial-mesenchymal transition,participation in multiple signaling pathways,and epigenetic modifications.Understanding the role of LINC01503 in cancer can have implications for the diagnosis,treatment,and prognosis assessment of related malignancies.This article provides a comprehensive review of the expression and molecular regulatory research progress of LINC01503 in relevant tumors.

Long non-coding RNALINC01503TumorMolecular regulation

沙湘钧、刘斯迪、张鑫淼、姜兴明

展开 >

哈尔滨医科大学附属第二医院普通外科,黑龙江哈尔滨 150086

长链非编码RNA LINC01503 肿瘤 分子调控

黑龙江省博士后科研启动金资助项目

LBH-Q21023

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(6)
  • 43